Last Updated: November 9, 2026

Perrigo Company Profile

« Back to Dashboard

What is the competitive landscape for PERRIGO

PERRIGO has one hundred and thirteen approved drugs.

There are three tentative approvals on PERRIGO drugs.

Summary for Perrigo

US Patents:	0
Tradenames:	66
Ingredients:	56
NDAs:	113
Patent Litigation for Perrigo:	See patent lawsuits for Perrigo
PTAB Cases with Perrigo as petitioner:	See PTAB cases with Perrigo as petitioner

Drugs and US Patents for Perrigo

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Perrigo R And D	FAMOTIDINE	famotidine	TABLET;ORAL	077352-002	Jul 27, 2005		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo New York	HYDROCORTISONE	hydrocortisone	OINTMENT;TOPICAL	085028-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo New York	HYDROCORTISONE	hydrocortisone	OINTMENT;TOPICAL	084969-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo R And D	FAMOTIDINE	famotidine	TABLET;ORAL	077351-001	Sep 25, 2006		OTC	No	No		⤷ Start Trial				⤷ Start Trial
Perrigo R And D	CETIRIZINE HYDROCHLORIDE HIVES	cetirizine hydrochloride	TABLET;ORAL	078336-004	Dec 27, 2007		OTC	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.